Insider Trading February 26, 2026

Entegris Executive Chair Loy Bertrand Disposes $15.1 Million in Shares, Exercises Options

Insider sale coincides with recent strong share gains and upbeat quarterly results that prompted analyst price-target increases

By Avery Klein ENTG
Entegris Executive Chair Loy Bertrand Disposes $15.1 Million in Shares, Exercises Options
ENTG

Entegris INC Executive Chair Bertrand Loy sold 111,000 shares across February 24 and 25, 2026, for roughly $15.1 million and exercised options for 9,838 shares on February 24. The transactions follow a six-month, 61% stock rally and come amid a Q4 2025 earnings beat and several analyst price-target upgrades.

Key Points

  • Executive Chair Bertrand Loy sold 111,000 Entegris shares on February 24-25, 2026, for about $15.1 million at prices between $137.32 and $142.19, near the 52-week high of $142.50.
  • On February 24, Loy exercised options to acquire 9,838 shares at $98.11 for a total cost of $965,206; post-transactions direct ownership is 217,767 shares.
  • Entegris beat Q4 2025 estimates with EPS of $0.70 versus $0.66 expected and revenue of $824 million versus $811.04 million forecast; BMO and KeyBanc raised price targets, citing improving trends but modest near-term topline guidance.

Entegris INC (NASDAQ:ENTG) Executive Chair Bertrand Loy executed a substantial disposition of company stock late this month, selling 111,000 shares on February 24 and 25, 2026, for approximately $15.1 million. The shares changed hands at prices between $137.32 and $142.19, levels that sit close to the stock's 52-week high of $142.50.

On February 24, Loy also exercised options to purchase 9,838 shares of Entegris common stock at an exercise price of $98.11, representing a total acquisition cost of $965,206. After accounting for the sale and the option exercise, Loy's reported direct ownership in Entegris stands at 217,767 shares.

The insider activity occurs after a notable rise in Entegris share value - the stock has climbed 61% over the past six months and currently trades at a price-to-earnings ratio of 84.42.


Recent company performance and analyst response

Entegris reported fourth-quarter 2025 results that exceeded expectations. The company posted earnings per share of $0.70, above the consensus forecast of $0.66, a 6.06% surprise. Revenue for the period reached $824 million, topping the anticipated $811.04 million figure.

Following the quarterly release, BMO Capital raised its price target for Entegris to $148 and kept an Outperform rating. KeyBanc Capital Markets also lifted its price target, moving it to $156 from $111 while maintaining an Overweight rating. KeyBanc's note referenced the company's update as suggestive of a material recovery approaching, though it characterized the initial inflection as modest; published guidance implies roughly 4% topline growth for the first half.


Valuation and analyst activity

According to InvestingPro analysis, ENTG appears overvalued relative to its Fair Value. The platform also notes that 10 analysts have revised earnings estimates higher for the upcoming period. That observation is one of multiple analytical items available to subscribers through InvestingPro's suite of research tools, including a Pro Research Report covering ENTG and more than 1,400 U.S. equities.

This reporting presents the transactions, recent financial results, and analyst reactions without drawing conclusions beyond the stated facts.

Risks

  • Valuation risk - InvestingPro analysis indicates ENTG may be overvalued relative to its Fair Value, which could affect investor returns and market perception.
  • Market reaction to insider selling - The sale of 111,000 shares by the executive chair could prompt investor scrutiny and pressure on the stock, particularly given recent strong appreciation.
  • Modest near-term growth outlook - Company guidance implies only about 4% topline growth for the first half, which could temper expectations for more rapid recovery in semiconductor-related demand.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026